CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-03 | Sides David William Chief Operating Officer | Sale | −2,866 | $206.99 | $593K | 7,152 |
| 2021-03-03 | Murthy Mala Chief Financial Officer | Sale | −3,074 | $206.99 | $636K | 13,240 |
| 2021-03-03 | GOREVIC JASON N Chief Executive Officer | Sale | −12,685 | $206.99 | $2.6M | 523,634 |
| 2021-03-03 | GOREVIC JASON N Chief Executive Officer | Option exercise | +12,500 | 536,134 | ||
| 2021-03-03 | GOREVIC JASON N Chief Executive Officer | Option exercise · Restricted Stock Units | −12,500 | 0 | ||
| 2021-03-02 | Verstraete Stephany Chief Marketing Officer | Sale | −1,547 | $224.28 | $347K | 14,898 |
| 2021-03-02 | Verstraete Stephany Chief Marketing Officer | Option exercise | +1,807 | 16,705 | ||
| 2021-03-02 | Verstraete Stephany Chief Marketing Officer | Option exercise | +3,072 | 19,777 | ||
| 2021-03-02 | Verstraete Stephany Chief Marketing Officer | Option exercise · Restricted Stock Units | −1,807 | 3,615 | ||
| 2021-03-02 | Verstraete Stephany Chief Marketing Officer | Grant or award · Performance Stock Units | +9,218 | 9,218 | ||
| 2021-03-02 | Verstraete Stephany Chief Marketing Officer | Option exercise · Performance Stock Units | −3,072 | 6,146 | ||
| 2021-03-02 | Verstraete Stephany Chief Marketing Officer | Grant or award · Restricted Stock Units | +3,442 | 3,442 | ||
| 2021-03-02 | Vandervoort Adam C Chief Legal Officer, Secretary | Sale | −1,658 | $224.28 | $372K | 2,287 |
| 2021-03-02 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +1,941 | 4,228 | ||
| 2021-03-02 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +3,300 | 7,528 | ||
| 2021-03-02 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Restricted Stock Units | −1,941 | 3,883 | ||
| 2021-03-02 | Vandervoort Adam C Chief Legal Officer, Secretary | Grant or award · Performance Stock Units | +9,900 | 9,900 | ||
| 2021-03-02 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Performance Stock Units | −3,300 | 6,600 | ||
| 2021-03-02 | Vandervoort Adam C Chief Legal Officer, Secretary | Grant or award · Restricted Stock Units | +5,736 | 5,736 | ||
| 2021-03-02 | Turitz Andrew SVP - Business Development | Sale | −695 | $224.28 | $156K | 5,625 |
Page 78 of 93 · 1,848 trades